Login
Super Investors BML Capital Management, LLC
BC

BML Capital Management, LLC

Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.

Portfolio value
$188M
Positions
20
Quarter ended
September 30, 2026
Filed
November 06, 2026

Reported portfolio value by quarter (16 quarters reported)

$188M $105M
Q4 22 Q4 23 Q4 24 Q4 25 Q3 26

$105M in Q4 2022 → $188M now. Hover for any quarter.

Holdings

As reported for the quarter ended September 30, 2026. Activity is the change in share count since the prior quarter's filing.

Holding % of portfolio Activity Shares Value
Aclaris Therapeutics Inc 30.7% Trimmed 8.5% 10,955,000 $57.6M
Atea Pharmaceuticals Inc 18.8% Trimmed 2.9% 6,753,658 $35.2M
Engene Therapeutics Inc 7.1% Unchanged 6,669,908 $13.3M
Pmv Pharmaceuticals Inc 6.5% Added 38% 7,330,000 $12.2M
Kraft Heinz Co 5.8% Added 2.2% 475,000 $10.8M
Tillys Inc 5.3% Unchanged 2,150,000 $9.95M
Carmax Inc 5.1% Unchanged 172,500 $9.51M
OM Outset Med Inc 4.0% Unchanged 2,519,701 $7.56M
Target Corp 3.1% Unchanged 37,500 $5.88M
Seer Inc 2.6% New 2,186,587 $4.88M
Instil Bio Inc 2.5% Unchanged 645,600 $4.67M
CB Connect Biopharma Hldgs Ltd 2.3% Added 574% 3,864,400 $4.25M
Oramed Pharmaceuticals Inc 2.2% Added 2.1% 884,392 $4.13M
Janux Therapeutics Inc 1.4% Trimmed 2.5% 151,126 $2.61M
Pliant Therapeutics Inc 0.9% Unchanged 1,546,137 $1.67M
Lenz Therapeutics Inc 0.6% New 283,114 $1.09M
Imagenebio Inc 0.5% Unchanged 200,730 $919K
Tesla Inc Put 0.4% Trimmed 60% 150 $696K
Walmart Inc Put 0.3% Unchanged 335 $538K
Karyopharm Therapeutics Inc 0.0% New 71,839 $87.6K

Timeline of changes

What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.

Q3 2026

quarter ended September 30, 2026 · filed November 06, 2026

Company Action Shares changed Value of change % of portfolio
Aclaris Therapeutics Inc Trimmed −1,020,000 −$5.37M 30.7%
Seer Inc New +2,186,587 +$4.88M 2.6%
CB Connect Biopharma Hldgs Ltd Added +3,291,113 +$3.62M 2.3%
Pmv Pharmaceuticals Inc Added +2,000,000 +$3.34M 6.5%
Lenz Therapeutics Inc New +283,114 +$1.09M 0.6%
Tesla Inc Trimmed −225 −$1.04M 0.4%
Atea Pharmaceuticals Inc Trimmed −198,672 −$1.04M 18.8%
CS Core Scientific Inc New Exited −800 −$298K —
Kraft Heinz Co Added +10,000 +$227K 5.8%
Karyopharm Therapeutics Inc New +71,839 +$87.6K —

Showing the 10 largest of 12 changes.

Q2 2026

quarter ended June 30, 2026 · filed August 07, 2026

Company Action Shares changed Value of change % of portfolio
Aclaris Therapeutics Inc Trimmed −2,275,000 −$12M 36.0%
Engene Therapeutics Inc New +6,669,908 +$11.5M 6.6%
Oramed Pharmaceuticals Inc Trimmed −2,300,962 −$11.1M 2.4%
Kraft Heinz Co Added +340,000 +$8.03M 6.2%
Kezar Life Sciences Inc Exited −720,787 −$5.35M —
OM Outset Med Inc Added +617,500 +$2.67M 6.2%
Carmax Inc Added +17,500 +$926K 5.2%
Atea Pharmaceuticals Inc Trimmed −106,327 −$494K 18.4%
CB Connect Biopharma Hldgs Ltd Added +164,400 +$391K 0.8%
CS Core Scientific Inc New New +800 +$298K 0.2%

Showing the 10 largest of 12 changes.

Q1 2026

quarter ended March 31, 2026 · filed May 06, 2026

Company Action Shares changed Value of change % of portfolio
Tillys Inc New +2,150,000 +$8.71M 5.6%
OM Outset Med Inc Added +1,359,021 +$5.22M 4.7%
Kraft Heinz Co New +125,000 +$2.81M 1.8%
Atea Pharmaceuticals Inc Trimmed −431,343 −$2.32M 24.4%
Janux Therapeutics Inc New +154,961 +$2.15M 1.4%
Carvana Co Exited −150 −$2.02M —
Tesla Inc Exited −1,000 −$205K —
Lisata Therapeutics Inc Exited −73,348 −$136K —
Imagenebio Inc Added +23,704 +$119K 0.6%
Pmv Pharmaceuticals Inc Added +28,000 +$34.7K 4.2%

Q4 2025

quarter ended December 31, 2025 · filed February 03, 2026

Company Action Shares changed Value of change % of portfolio
Adverum Biotechnologies Inc Exited −3,057,526 −$13.9M —
Carmax Inc New +155,000 +$5.99M 5.2%
Alumis Inc Exited −1,210,415 −$4.83M —
Lava Therapeutics Nv Exited −1,970,610 −$3.07M —
Target Corp Added +27,500 +$2.69M 3.2%
CB Connect Biopharma Hldgs Ltd Trimmed −858,613 −$2.42M 1.0%
Carvana Co New +150 +$2.02M 1.7%
OM Outset Med Inc New +543,180 +$2.02M 1.7%
Pliant Therapeutics Inc New +1,546,137 +$1.89M 1.6%
Athira Pharma Inc Exited −323,066 −$1.34M —

Showing the 10 largest of 20 changes.

Q3 2025

quarter ended September 30, 2025 · filed November 10, 2025

Company Action Shares changed Value of change % of portfolio
Essa Pharma Inc Exited −4,221,546 −$7.18M —
Ikena Oncology Inc Exited −4,030,102 −$5.4M —
MP Milestone Pharmaceuticals In Exited −1,136,091 −$2.2M —
Elevation Oncology Inc Exited −5,890,434 −$2.16M —
Instil Bio Inc Added +110,701 +$1.98M 10.6%
CB Connect Biopharma Hldgs Ltd New +1,267,500 +$1.91M 1.8%
CB Connect Biopharma Hldgs Ltd Exited −1,821,558 −$1.79M —
Tesla Inc Exited −200 −$1.65M —
Imagenebio Inc New +182,509 +$1.49M 1.4%
Athira Pharma Inc New +323,066 +$1.34M 1.2%

Showing the 10 largest of 24 changes.

Q2 2025

quarter ended June 30, 2025 · filed August 11, 2025

Company Action Shares changed Value of change % of portfolio
An2 Therapeutics Inc Exited −5,749,432 −$7.82M —
Alumis Inc Added +1,160,788 +$3.48M 2.7%
Whitehawk Therapeutics Inc Exited −1,890,245 −$3.36M —
Instil Bio Inc Added +118,179 +$2.46M 8.4%
Tesla Inc New +200 +$1.65M 1.3%
Pmv Pharmaceuticals Inc Added +1,252,388 +$1.33M 4.0%
Sage Therapeutics Inc Exited −135,095 −$1.07M —
Kezar Life Sciences Inc Added +227,045 +$1.04M 2.2%
Adverum Biotechnologies Inc Added +315,209 +$678K 5.0%
Corvus Pharmaceuticals Inc New +118,766 +$475K 0.4%

Showing the 10 largest of 20 changes.

Q1 2025

quarter ended March 31, 2025 · filed May 07, 2025

Company Action Shares changed Value of change % of portfolio
IT Ishares Tr Exited −260,000 −$26.1M —
Third Harmonic Bio Inc New +3,824,417 +$13.3M 10.7%
Lava Therapeutics Nv New +1,960,610 +$2.49M 2.0%
Adverum Biotechnologies Inc Added +474,253 +$2.07M 9.7%
Kezar Life Sciences Inc Added +359,470 +$1.75M 1.6%
Elevation Oncology Inc New +5,890,934 +$1.53M 1.2%
Sage Therapeutics Inc New +135,095 +$1.07M 0.9%
Oramed Pharmaceuticals Inc Added +376,841 +$806K 5.2%
PT Palvella Therapeutics Inc Ne Exited −42,130 −$506K —
Turnstone Biologics Corp New +1,103,386 +$452K 0.4%

Showing the 10 largest of 21 changes.

Q4 2024

quarter ended December 31, 2024 · filed February 07, 2025

Company Action Shares changed Value of change % of portfolio
SS SPDR Ser Tr Exited −175,000 −$16.1M —
Essa Pharma Inc New +4,221,546 +$7.56M 4.7%
Tectonic Therapeutic Inc Exited −211,752 −$6.42M —
Reneo Pharmaceuticals Inc Exited −3,457,395 −$5.88M —
Ikena Oncology Inc Added +2,862,578 +$4.69M 3.7%
Atea Pharmaceuticals Inc Added +958,312 +$3.21M 15.8%
Pmv Pharmaceuticals Inc Added +1,777,912 +$2.68M 3.3%
Athira Pharma Inc New +2,775,885 +$1.63M 1.0%
Lenz Therapeutics Inc Trimmed −50,729 −$1.46M 0.2%
Instil Bio Inc Added +65,000 +$1.24M 4.7%

Showing the 10 largest of 24 changes.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support